Document is current

Article History

Received: 6 October 2022

Accepted: 25 January 2023

First Online: 5 April 2023

Declarations

:

: This study involved de-identified, aggregate data and was not subject to Institutional Review Board approval at Merck & Co., Inc., Rahway, NJ, USA or Analysis Group, Inc. Informed consent was not needed as all patients were anonymized and only aggregate data are reported here. A research review committee at Merck & Co., Inc., Rahway, NJ, USA approved the study protocol prior to the study initiation. All methods were performed in accordance with the relevant guidelines and regulations, including the principles of the Declaration of Helsinki.

: Not applicable.

: EMS, SM, and TW are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. TH was an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, at the time the study was conducted. YS, ND, QL, ELW, and JS are employees of Analysis Group Inc., a consulting firm that received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, to conduct this study.